Confirmation of lipid hypothesis in SEAS: Mortality risk stratification without lipids
![]() Confirmation of lipid hypothesis in SEAS: Mortality risk stratification without lipidsProf. Ingar Holme discusses the background and the main results of the SEAS trial. To further explain the outcomes of the trial, stratification by lipoprotein components and by aortic stenosis severity at baseline was performed. Prediction of the risk for ischemic events by lipid components is a valuable tool that will be further investigated.Questions to be addressed in this PACE expert opinion are:
View the expert opinion interview with prof. Holme |
About the speaker
Professor Ingar HolmeCentre for Preventive Medicine
Ullevåll University Hospital
Oslo, Norway
Teaching slides

Confirmation of lipid hypothesis in SEAS
Mortality risk stratification without lipids
Ingar Holme, MDCentre for Preventive Medicine
Ullevål University Hospital
Oslo, Norway
MC Lipid Innovations - May 2011
Share this page with your colleagues and friends: